Novozymes and Syngenta enter agreement
Novozymes, based in Copenhagen, Denmark, and Syngenta, based in Basel, Switzerland, have entered into an exclusive global marketing and distribution agreement on the microbial-based biofungicide Taegro, a natural solution with multiple modes of action to combat fungal diseases across various crops.
Taegro offers a biological solution in the form of a microbial-based fungicide, based on the naturally occurring Bacillus subtilis bacterium, which is complementary to existing fungicide technology. It effectively targets fungal diseases such as Rhizoctonia and Fusarium on fruit and vegetables, and its application is expected to be expanded to a wider portfolio of broad-acre crops such as wheat, soy and corn.
Under the terms of the agreement, Novozymes and Syngenta will share the task of bringing Taegro to market. Syngenta will be responsible for sales, marketing and distribution, while Novozymes will be responsible for production and registration. Trials are planned to secure data to continue to build on the current U.S. registration in other regions, and then the two companies will aim for a global rollout.
Financial details of the agreement were not disclosed.